LATAM Daily Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.

Press releases published on September 24, 2026

12 hours ago

SK pharmteco bringt ein Catalyst Kit zur Entwicklung katalytischer Reaktionen und Skalierung der kontinuierlichen Produktion auf den Markt

Indeterminate GlobeNewswire

12 hours ago

SK pharmteco lance un kit de catalyseurs destiné à rationaliser le développement des réactions catalytiques et leur mise à l’échelle en fabrication continue

Indeterminate GlobeNewswire

13 hours ago

Red Cat Celebrates Inaugural Blue Ops Day in Georgia, Marking a Year of Growth in U.S. Maritime Manufacturing

Indeterminate GlobeNewswire

13 hours ago

NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst

Indeterminate GlobeNewswire

14 hours ago

Bitget's Multi-Asset KCGI 2026 Draws More Than 83,000 Traders

Indeterminate GlobeNewswire

14 hours ago

Bitget atrae a más de 83.000 traders a su KCGI 2026 multiactivos

Indeterminate GlobeNewswire

14 hours ago

La compétition multi-actifs KCGI 2026 de Bitget a attiré plus de 83 000 traders

Indeterminate GlobeNewswire

14 hours ago

KCGI 2026 מרובה הנכסים של Bitget משך יותר מ-83,000 סוחרים

Indeterminate GlobeNewswire

14 hours ago

ビットゲットのマルチアセットKCGI 2026に8万3,000人以上のトレーダーが参加

Indeterminate GlobeNewswire

14 hours ago

Bitget 멀티에셋 KCGI 2026에 8만3,000명 이상 트레이더 참가

Indeterminate GlobeNewswire

14 hours ago

KCGI 2026 Pelbagai Aset Anjuran Bitget Menarik Lebih 83,000 Pedagang

Indeterminate GlobeNewswire

14 hours ago

Bitget 的多資產 KCGI 2026 吸引超過 83,000 名交易者

Indeterminate GlobeNewswire

14 hours ago

KCGI 2026 de Multiativos da Bitget Atrai Mais de 83.000 Traders

Indeterminate GlobeNewswire

14 hours ago

Bitget 多资产 KCGI 2026 吸引超 83,000 名交易者参与

Indeterminate GlobeNewswire

15 hours ago

SK pharmteco Launches Catalyst Kit to Streamline Catalytic Reaction Development and Continuous Manufacturing Scale-Up

Indeterminate GlobeNewswire

15 hours ago

Persevere Therapeutics Announces Treatment of First Patient in its MIROC-1 Phase 2a Ovarian Cancer Clinical Trial

Indeterminate GlobeNewswire

15 hours ago

Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference

Indeterminate GlobeNewswire

16 hours ago

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Indeterminate GlobeNewswire

16 hours ago

EBANX advances emerging market infrastructure with Pakistan expansion in motion and native Apple Pay decryption

Indeterminate GlobeNewswire

16 hours ago

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire